Image showing sections of cerebral brain organoids derived from pluripotent stem cells.
via Agnieszka Rybak-Wolf, MDC/LifeTime
Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.
The LifeTime initiative, co-coordinated by the Max Delbrück Center of Molecular Medicine in the Helmholtz Association (MDC) in Berlin and the Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases. The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.
Earlier detection and more effective treatment of diseases
To form a functioning, healthy body, our cells follow developmental paths during which they acquire specific roles in tissues and organs. But when they deviate from their healthy course, they accumulate changes leading to disease which remain undetected until symptoms appear. At this point, medical treatment is often invasive, expensive and inefficient. However, now we have the technologies to capture the molecular makeup of individual cells and to detect the emergence of disease or therapy resistance much earlier.
Using breakthrough single-cell and imaging technologies in combination with artificial intelligence and personalized disease models will allow us to not only predict disease onset earlier, but also to select the most effective therapies for individual patients. Targeting disease-causing cells to intercept disorders before irreparable damage occurs will substantially improve the outlook for many patients and has the potential of saving billions of Euros of disease-related costs in Europe.
A detailed roadmap for implementing LifeTime
The perspective article “The LifeTime initiative and the future of cell-based interceptive medicine in Europe” and the LifeTime Strategic Research Agenda (SRA) explain how these technologies should be rapidly co-developed, transitioned into clinical settings and applied to the five major disease areas. Close interactions between European infrastructures, research institutions, hospitals and industry will be essential to generate, share and analyze LifeTime’s big medical data across European borders. The initiative’s vision advocates ethically responsible research to benefit citizens all across Europe.
According to Professor Nikolaus Rajewsky, scientific director of the Berlin Institute for Medical System Biology at the Max Delbrück Center for Molecular Medicine and coordinator of the LifeTime Initiative, the LifeTime approach is the way into the future: “LifeTime has brought together scientists across fields – from biologists, to clinicians, data scientists, engineers, mathematicians, and physicists – to enable a much improved understanding of molecular mechanisms driving health and disease. Cell-based medicine will allow doctors to diagnose diseases earlier and intercept disorders before irreparable damage has occurred. LifeTime has a unique value proposition that promises to improve the European patient’s health.”
Dr. Geneviève Almouzni, director of research at CNRS, honorary director of the research center from Institut Curie in Paris and co-coordinator of the LifeTime Initiative believes that the future with LifeTime offers major social and economic impact: “By implementing interceptive, cell-based medicine we will be able to considerably improve treatment across many diseases. Patients all over the world will be able to lead longer, healthier lives. The economic impact could be tremendous with billions of Euros saved from productivity gains simply for cancer, and significantly shortened ICU stays for Covid-19. We hope EU leaders will realize we have to invest in the necessary research now.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cell-based interceptive medicine
- Stem Cells News
Genetically Modified Pluripotent Stem Cells May Evade Immunological Rejection After Transplantation, Study Shows Jan. 11, 2024 — One of the biggest barriers to regenerative medicine is ...
- 5 Cell and Gene Therapy Decisions to Watch in 2024
All signs point to 2024 surpassing 2023 as a landmark year for cell and gene therapy,” David Barrett, CEO of the American Society of Gene & Cell Therapy (ASGCT), told BioSpace. The first approval this ...
- HeLa cells: The most influential and controversial discovery in medicine
These are just a few of the life-changing developments in medicine made possible by the cells of Henrietta Lacks. One would imagine the compensation and rewards for providing such an incredible ...
- Cell Therapies, Vaccines May Work Better If T Cells Have More NAD(H)
“With more work, we also believe that this information could potentially be used to improve vaccine strategies and the response and durability of cell-based therapies used to treat cancer and ...
- Hijacking Viruses: Optimizing Lentivirus-Based Cell Engineering
Researchers commonly employ lentiviruses to modify cells genetically. However ... nucleic acid delivery applications and is establishing the future of science and medicine by developing products that ...
Go deeper with Google Headlines on:
Cell-based interceptive medicine
[google_news title=”” keyword=”cell-based interceptive medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
LifeTime Initiative
- ABS-CBN Film Restoration receives Lifetime Achievement honor
ABS-CBN Film Restoration has been recognized as a film industry icon for its efforts in local film preservation and restoration after receiving a Lifetime Achievement Award from the prestigious ...
- City hopes new initiative will help solve affordable housing problem in Wichita
With entire city-owned neighborhoods full of abandoned homes, some full of bullet holes, the city faced some scrutiny about the lack of affordable housing when it chose to sell them all off. But now i ...
- Houston Man Sentenced to 15 Years for Sexually Abusing Minor in Tulsa, Lifetime Supervised Release Ordered
Houston man sentenced to 15 years for traveling to Tulsa to sexually abuse a minor; will also face lifetime supervision and sex offender registration.
- Watertown to start week-long tree-planting initiative today
The City of Watertown will start a week-long tree-planting program starting today in honor of Arbor Day. The festivities kick off at 10 a.m. today as part of the City’s 27th annual Arbor Day Ceremony ...
- Shred Station Named First-Ever Lifetime Carbon Neutral Waste Company
A shredding service provider has achieved a UK waste management industry first, reaching lifetime carbon neutrality in line with The Carbon Neutral Protocol.
Go deeper with Google Headlines on:
LifeTime initiative
[google_news title=”” keyword=”LifeTime initiative” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]